We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.64%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$106B
AUM Growth
+$2.27B
(+2.2%)
Cap. Flow
-$488M
Cap. Flow
% of AUM
-0.46%
Top 10 Holdings %
Top 10 Hldgs %
30.07%
Holding
4,478
New
179
Increased
2,056
Reduced
1,848
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$101M |
| 2 |
GE Vernova
GEV
|
+$75.4M |
| 3 |
CRH
CRH
|
+$48.5M |
| 4 |
CrowdStrike
CRWD
|
+$45.8M |
| 5 |
Dell
DELL
|
+$35.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$180M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$121M |
| 3 |
GE Aerospace
GE
|
+$59.1M |
| 4 |
UnitedHealth
UNH
|
+$46.6M |
| 5 |
NVIDIA
NVDA
|
+$38.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.98% |
| 2 | Financials | 12.55% |
| 3 | Healthcare | 11.48% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Immunovant
IMVT
$8.25B
| $2.21M | ﹤0.01% |
83,532
+7,363
| +10% | +$209K |
|
1827
Liberty Latin America Class C
LILAK
$1.64B
| $2.2M | ﹤0.01% |
252,040
-5,499
| -2% | -$41K |
|
1828
Clarivate
CLVT
$1.16B
| $2.2M | ﹤0.01% |
387,341
-49,996
| -11% | -$319K |
|
1829
iShares MSCI Kuwait ETF
KWT
$68.4M
| $2.2M | ﹤0.01% |
70,510
| – | – |
|
1830
Enviri
NVRI
$620M
| $2.2M | ﹤0.01% |
254,653
-2,666
| -1% | -$22.2K |
|
|
SCS
1831
DELISTED
Steelcase
SCS
| $2.2M | ﹤0.01% |
169,562
+3,734
| +2% | +$47.6K |
|
1832
Capitol Federal Financial
CFFN
$1.1B
| $2.19M | ﹤0.01% |
399,714
-9,227
| -2% | -$48.1K |
|
1833
AMC Entertainment Holdings
AMC
$2.31B
| $2.18M | ﹤0.01% |
437,501
+262,701
| +150% | +$1.06M |
|
1834
Howard Hughes
HHH
$4.03B
| $2.18M | ﹤0.01% |
35,258
-3,212
| -8% | -$201K |
|
1835
Rocket Pharmaceuticals
RCKT
$394M
| $2.18M | ﹤0.01% |
101,134
+4,958
| +5% | +$114K |
|
1836
Stock Yards Bancorp
SYBT
$2.6B
| $2.17M | ﹤0.01% |
43,766
+4,207
| +11% | +$196K |
|
|
LADR
1837
Ladder Capital
LADR
$1.24B
| $2.17M | ﹤0.01% |
192,242
+3,311
| +2% | +$36.3K |
|
|
SPTN
1838
DELISTED
SpartanNash
SPTN
| $2.16M | ﹤0.01% |
114,940
-1,342
| -1% | -$26.2K |
|
1839
Astec Industries
ASTE
$1.02B
| $2.15M | ﹤0.01% |
72,542
-2,837
| -4% | -$102K |
|
|
ONT
1840
Onterris Inc
ONT
$580M
| $2.15M | ﹤0.01% |
48,215
+4,702
| +11% | +$212K |
|
|
EVBG
1841
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $2.15M | ﹤0.01% |
61,361
+5,027
| +9% | +$175K |
|
1842
Kura Oncology
KURA
$850M
| $2.14M | ﹤0.01% |
104,176
-9,432
| -8% | -$194K |
|
|
HPP
1843
Hudson Pacific Properties
HPP
$779M
| $2.14M | ﹤0.01% |
63,512
-579
| -0.9% | -$21.8K |
|
|
TRST
1844
Trustco Bank Corp NY
TRST
$938M
| $2.13M | ﹤0.01% |
74,058
-944
| -1% | -$25.9K |
|
1845
Vir Biotechnology
VIR
$1.49B
| $2.12M | ﹤0.01% |
238,504
+9,817
| +4% | +$94.1K |
|
1846
AST SpaceMobile
ASTS
$21.5B
| $2.11M | ﹤0.01% |
181,966
+64,658
| +55% | +$338K |
|
1847
First Busey Corp
BUSE
$2.58B
| $2.11M | ﹤0.01% |
87,257
+1,164
| +1% | +$26.6K |
|
1848
HealthStream
HSTM
$839M
| $2.11M | ﹤0.01% |
75,684
+331
| +0.4% | +$8.82K |
|
1849
Recursion Pharmaceuticals
RXRX
$1.72B
| $2.11M | ﹤0.01% |
281,348
+54,576
| +24% | +$476K |
|
|
SHOE
1850
Shoe Station Group
SHOE
$428M
| $2.09M | ﹤0.01% |
56,711
+394
| +0.7% | +$14K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2024 Portfolio in Review
As of Q2 2024, RhumbLine Advisers held 4,478 positions worth $106B, up 2.2% from $104B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
RhumbLine Advisers's Q2 2024 filing shows 179 new, 2,056 increased, 1,848 reduced and 61 closed positions. Its largest new stake was GE Vernova: 475,685 shares worth $81.6M. The largest sale was iShares Russell 1000 ETF, an estimated $180M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q2 2024 buy was GE Vernova: 475,685 shares worth $81.6M.
- RhumbLine Advisers added most to ExxonMobil in Q2 2024, an estimated $101M increase.
- RhumbLine Advisers's biggest Q2 2024 reduction was iShares Russell 1000 ETF, cutting an estimated $180M.
- RhumbLine Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $121M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $106B portfolio in Q2 2024.
- RhumbLine Advisers opened 179 new positions and closed 61 in Q2 2024.
- RhumbLine Advisers's portfolio value rose 2.2% quarter-over-quarter to $106B.
Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.